Irritable Bowel Syndrome Treatment Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 - 2030
CHAPTER 1. Industry Overview of Irritable Bowel Syndrome Treatment Market
1.1. Definition and Scope
1.1.1. Definition of Irritable Bowel Syndrome Treatment
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Irritable Bowel Syndrome Treatment Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Irritable Bowel Syndrome Treatment Market By Type
1.2.3. Irritable Bowel Syndrome Treatment Market By Product
1.2.4. Irritable Bowel Syndrome Treatment Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Irritable Bowel Syndrome Treatment Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Irritable Bowel Syndrome Treatment Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Irritable Bowel Syndrome Treatment Market By Type
4.1. Introduction
4.2. Irritable Bowel Syndrome Treatment Revenue By Type
4.2.1. Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast, By Type, 2018-2030
4.2.2. IBS-D
4.2.2.1. IBS-D Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.2.2. Viberzi
4.2.2.2.1. Viberzi Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.2.3. Xifaxan
4.2.2.3.1. Xifaxan Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.2.4. Others
4.2.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3. IBS-C
4.2.3.1. IBS-C Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3.2. Amitiza
4.2.3.2.1. Amitiza Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3.3. Linzess/Constella
4.2.3.3.1. Linzess/Constella Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3.4. Others
4.2.3.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 5. Irritable Bowel Syndrome Treatment Market By Application
5.1. Introduction
5.2. Irritable Bowel Syndrome Treatment Revenue By Application
5.2.1. Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast, By Application, 2018-2030
5.2.2. Viberzi
5.2.2.1. Viberzi Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3. Linzess/Constella
5.2.3.1. Linzess/Constella Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.4. Xifaxan
5.2.4.1. Xifaxan Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.5. Amitiza
5.2.5.1. Amitiza Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.6. Others
5.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 6. North America Irritable Bowel Syndrome Treatment Market By Country
6.1. North America Irritable Bowel Syndrome Treatment Market Overview
6.2. U.S.
6.2.1. U.S. Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Type, 2018-2030
6.2.2. U.S. Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
6.3. Canada
6.3.1. Canada Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Type, 2018-2030
6.3.2. Canada Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
6.4. North America PEST Analysis
CHAPTER 7. Europe Irritable Bowel Syndrome Treatment Market By Country
7.1. Europe Irritable Bowel Syndrome Treatment Market Overview
7.2. U.K.
7.2.1. U.K. Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Type, 2018-2030
7.2.2. U.K. Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
7.3. Germany
7.3.1. Germany Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Type, 2018-2030
7.3.2. Germany Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
7.4. France
7.4.1. France Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Type, 2018-2030
7.4.2. France Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
7.5. Spain
7.5.1. Spain Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Type, 2018-2030
7.5.2. Spain Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
7.6. Rest of Europe
7.6.1. Rest of Europe Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Type, 2018-2030
7.6.2. Rest of Europe Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
7.7. Europe PEST Analysis
CHAPTER 8. Asia Pacific Irritable Bowel Syndrome Treatment Market By Country
8.1. Asia Pacific Irritable Bowel Syndrome Treatment Market Overview
8.2. China
8.2.1. China Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Type, 2018-2030
8.2.2. China Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
8.3. Japan
8.3.1. Japan Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Type, 2018-2030
8.3.2. Japan Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
8.4. India
8.4.1. India Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Type, 2018-2030
8.4.2. India Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
8.5. Australia
8.5.1. Australia Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Type, 2018-2030
8.5.2. Australia Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
8.6. South Korea
8.6.1. South Korea Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Type, 2018-2030
8.6.2. South Korea Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
8.7. Rest of Asia-Pacific
8.7.1. Rest of Asia-Pacific Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Type, 2018-2030
8.7.2. Rest of Asia-Pacific Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
8.8. Asia Pacific PEST Analysis
CHAPTER 9. Latin America Irritable Bowel Syndrome Treatment Market By Country
9.1. Latin America Irritable Bowel Syndrome Treatment Market Overview
9.2. Brazil
9.2.1. Brazil Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Type, 2018-2030
9.2.2. Brazil Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
9.3. Mexico
9.3.1. Mexico Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Type, 2018-2030
9.3.2. Mexico Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
9.4. Rest of Latin America
9.4.1. Rest of Latin America Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Type, 2018-2030
9.4.2. Rest of Latin America Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
9.5. Latin America PEST Analysis
CHAPTER 10. Middle East & Africa Irritable Bowel Syndrome Treatment Market By Country
10.1. Middle East & Africa Irritable Bowel Syndrome Treatment Market Overview
10.2. GCC
10.2.1. GCC Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Type, 2018-2030
10.2.2. GCC Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
10.3. South Africa
10.3.1. South Africa Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Type, 2018-2030
10.3.2. South Africa Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
10.4. Rest of Middle East & Africa
10.4.1. Rest of Middle East & Africa Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Type, 2018-2030
10.4.2. Rest of Middle East & Africa Irritable Bowel Syndrome Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
10.5. Middle East & Africa PEST Analysis
CHAPTER 11. Player Analysis Of Irritable Bowel Syndrome Treatment Market
11.1. Irritable Bowel Syndrome Treatment Market Company Share Analysis
11.2. Competition Matrix
11.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
11.2.2. New Product Launches and Product Enhancements
11.2.3. Mergers And Acquisition In Global Irritable Bowel Syndrome Treatment Market
11.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 12. Company Profile
12.1. Allergan
12.1.1. Company Snapshot
12.1.2. Business Overview
12.1.3. Financial Overview
12.1.3.1. Revenue (USD Million), 2021
12.1.3.2. Allergan AG 2021 Irritable Bowel Syndrome Treatment Business Regional Distribution
12.1.4. Product /Service and Specification
12.1.5. Recent Developments & Business Strategy
12.2. Ironwood Pharmaceuticals, Inc.
12.3. Synergy Pharmaceuticals Inc.
12.4. Bausch Health
12.5. Takeda Pharmaceutical Company Limited
12.6. AstraZeneca
12.7. Sebela Pharmaceuticals Inc.
12.8. Synthetic Biologics, Inc.
12.9. Astellas Pharma, Inc.
12.10. Ardelyx
Frequently Asked Questions
What is the size of global irritable bowel syndrome treatment market in 2021?
The market size of irritable bowel syndrome treatment market in 2021 was accounted to be USD 2.1 Billion.
What is the CAGR of global irritable bowel syndrome treatment market during forecast period of 2022 to 2030?
The projected CAGR of irritable bowel syndrome treatment market during the analysis period of 2022 to 2030 is 9.5%.
Which are the key players operating in the market?
The prominent players of the global irritable bowel syndrome treatment market are Allergan, Ironwood Pharmaceuticals, Inc., Synergy Pharmaceuticals Inc., Bausch Health, Takeda Pharmaceutical Company Limited, AstraZeneca, Sebela Pharmaceuticals Inc., Synthetic Biologics, Inc., Astellas Pharma, Inc., and Ardelyx.
Which region held the dominating position in the global irritable bowel syndrome treatment market?
North America held the dominating irritable bowel syndrome treatment during the analysis period of 2022 to 2030.
Which region registered the fastest growing CAGR for the forecast period of 2022 to 2030?
Asia-Pacific region exhibited fastest growing CAGR for irritable bowel syndrome treatment during the analysis period of 2022 to 2030.
What are the current trends and dynamics in the global irritable bowel syndrome treatment market?
Rising prevalence of IBS, increasing incidences of gastrointestinal disorders, and growing geriatric population drives the growth of global irritable bowel syndrome treatment market.
Which type held the maximum share in 2021?
Based on type, IBS-D segment is expected to hold the maximum share irritable bowel syndrome treatment market.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
